• Icon International Neuroendocrine Cancer Alliance

  • Mail: post@incalliance.org

Tag: Global survey

Masterclass_header
ESO Masterclass in Cancer Patient Advocacy

INCA has had the pleasure of participating in the 2nd Masterclass in Cancer Patient Advocacy: Working Towards Stronger and More Effective Advocacy in Europe, taking place on 24-26 June in Milan, Italy.

 

INCA shares best practice

Evidence-based activism at the 2nd Masterclass in Cancer Patient Advocacy held by European School of Oncology (ESO)

Read More
survey time
Quality of life – Survey

  Results from the survey “Quality-of-life”, patients with neuroendocrine tumors (NET)1. The survey gathered information on the NET patient experience, including diagnosis, disease impact and management, quality of life, and knowledge and awareness levels.   Quality of life results Multidisciplinary approach Challenges of diagnosing   “This is the first time the NET patient experience has…

Read More
ENETS-Leyden web2
Quality of life – at ENETS

  Results from the global survey “Quality-of-life”, patients with neuroendocrine tumors (NET)1. Presented at ENETS, European Neuroendocrine Tumor Society, in Barcelona. NET Cancer patient experience, including diagnosis, disease impact and management, quality of life, and knowledge and awareness levels.                 Patient Perspective  Time to Diagnosis  Multidisciplinary team  Patient Experience…

Read More
survey iweb1
Global NET patient survey

The International Neuroendocrine Cancer Alliance (INCA) and Novartis presents the quality-of-life results from the first global survey of patients with neuroendocrine tumors (NETs), a rare type of cancer1.

Nearly 2,000 patients from 12 countries completed the survey, which was a collaborative effort between INCA and Novartis. The results were presented at a medical meeting and provide compelling data documenting the impact of NETs on people living with this disease1. These quality-of-life findings are the first in a series of results from the survey being released in conjunction with Worldwide NET Cancer Awareness Day (WNCAD), November 10.

Read More
Copyright © 2015 International Neuroendocrine Cancer Alliance. All right reserved.
Make a Donation
Paybal button